[Acute coronary syndrome with ST segment depression on ECG: novel outlook of an old problem]
Insights
This study on acute coronary syndrome (ACS) with ST segment depressions found that trimetazidine improves patient outcomes. The research analyzed 501 patients, suggesting a new risk stratification scheme.
Area of Science:
- Cardiology
- Internal Medicine
Context:
- Focuses on acute coronary syndrome (ACS) with ST segment depressions on electrocardiogram (ECG).
- Examines clinical course, morphological manifestations, and prognostic features of this ACS variant.
- Investigates outcomes in a cohort of 501 patients.
Purpose:
- To analyze the clinical course and outcomes of ACS with ST segment depressions.
- To develop a risk stratification scheme for complicated ischemic heart disease.
- To evaluate the therapeutic efficacy of metabolic drugs in ACS patients.
Summary:
- Studied 501 patients with ACS and ST segment depressions, proposing a risk stratification scheme.
- Investigated 85 patients with ACS and ST segment depressions during anginal attacks.
- Assessed trimetazidine, polarizing mixtures, enalapril maleate, and potassium succinate as therapies.
Impact:
- Trimetazidine demonstrated improved disease course and prognosis in ACS patients.
- The study offers a potential new approach to managing ACS with ST segment depressions.
- Provides insights into risk stratification for ischemic heart disease complications.
Abstract:
The lecture is devoted to morphological manifestations, clinical and prognostic features of acute coronary syndrome (ACS) with ST segment depressions on ECG. We have studied peculiarities of clinical course of this variant of ACS and its outcomes in 501 patients and suggested a scheme for stratification of patients in groups of risk of complicated course of ischemic heart disease. We have also studied 85 patients with ACS with ST segment depressions on ECG during anginal attack. In therapy of these patients we included drugs with potential metabolic action: trimetazidine (n=29), infusions of polarizing mixture (n=16), enalapril maleate (n=28), potassium succinate (n=12). It has been established that the application of trimetazidine improves course and prognosis of the disease.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Acute Coronary Syndrome V: Nursing Management


